DWA
AMED

Dorsey Wright & Associates’s Amedisys AMED Stock Holding History

Dorsey Wright & Associates’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-21,118
Closed -$5.59K – 292
2021
Q1 		$5.59K Buy
21,118
+2,044
+11% +$576K 0.07% 171
2020
Q4 		$5.59M Buy
19,074
+489
+3% +$125K 0.83% 19
2020
Q3 		$4.39M Sell
18,585
-6,039
-25% -$1.37M 0.79% 27
2020
Q2 		$4.92M Buy
24,624
+4,182
+20% +$780K 1% 20
2020
Q1 		$3.75M Sell
20,442
-4,030
-16% -$717K 1.42% 20
2019
Q4 		$4.08M Buy
+24,472
New +$3.64M 1.35% 22

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Dorsey Wright & Associates's AMED Position: Q2 2021 in Review

Dorsey Wright & Associates sold out of Amedisys (AMED) in Q2 2021, closing a stake of 21,118 shares — an estimated $5.59K sold.

Dorsey Wright & Associates first reported a position in AMED in Q4 2019 and held it in 6 quarters. The position peaked at $5.59M in Q4 2020. 375 funds tracked by Wall St. Rank hold AMED as of Q2 2021.

  • Dorsey Wright & Associates reported no remaining Amedisys position as of Q2 2021 after selling out during the quarter.
  • Dorsey Wright & Associates sold 21,118 Amedisys shares in Q2 2021, an estimated $5.59K.
  • Dorsey Wright & Associates first reported a position in Amedisys in Q4 2019 and held it in 6 quarters.
  • Dorsey Wright & Associates's Amedisys position peaked at $5.59M in Q4 2020.
  • 375 funds tracked by Wall St. Rank held Amedisys as of Q2 2021.

Based on Dorsey Wright & Associates's 13F filing for Q2 2021, filed 23 Jul 2021.